Investor Relations

Based in Irvine, Calif., Axonics is a global medical technology company focused on the development and commercialization of novel products for patients with bladder and bowel dysfunction. The company’s rechargeable sacral neuromodulation system provides patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, and clinically effective therapy. In addition, Axonics’ best-in-class urethral bulking agent, Bulkamid^®, provides women suffering from stress urinary incontinence with safe and durable symptom relief. 

Bladder and bowel dysfunction significantly impacts quality of life for millions of adults in the U.S. and Europe. Axonics’ clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries.